In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the Director of the Office of Prescription Drug Promotion (OPDP) at the ...

Improved loss from operations by 31% - - Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health ...

Evofem Biosciences, Inc. ( (EVFM) ) has released its Q3 earnings. Here is a breakdown of the information Evofem Biosciences, Inc. presented to ...

Women's health innovator Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCQB: EVFM) today announced financial results ...

Nature's Miracle Holding Inc.  ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced its financial results for the third quarter ended ...

The New Home Company today announced that the Company will release its financial results for the fiscal 2024 fourth quarter on its confidential data site on Wednesday, November 20, 2024. The Company ...

For these, Aditxt has entered into an arrangement agreement with Appili Therapeutics Inc. (TSX: APLI) (OTC: APLIF) , which focuses on infectious diseases, and a merger agreement with Evofem. Each ...

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today provided an update to its shareholders on the ...